School of Pharmacy Launches Master’s in AI for Drug Development
The University of Maryland School of Pharmacy has launched a fully online Master of Science in Artificial Intelligence for Drug Development (MS in AIDD), with classes beginning in fall 2025. This interdisciplinary program emphasizes hands-on training in AI-enabled predictive analytics, machine learning, and natural language processing to accelerate innovation across all stages of drug development. The curriculum also addresses ethical considerations such as bias, privacy, and transparency, preparing graduates for careers in the pharmaceutical industry, academia, regulatory agencies, and AI-driven health care startups.